Evidence map›Paper›PMID 37446820›Full record

ArticleMolecules (Basel, Switzerland)2023

Insight into the Morphological Properties of Nano-Kaolinite (Nanoscrolls and Nanosheets) on Its Qualification as Delivery Structure of Oxaliplatin: Loading, Release, and Kinetic Studies.

Mashael Daghash Alqahtani, Nourhan Nasser, May N Bin Jumah, Saleha A AlZahrani, Ahmed A Allam, Mostafa R Abukhadra, Stefano Bellucci

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Mashael Daghash AlqahtaniDepartment of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0003-0043-0847
Nourhan NasserGeology Department, Faculty of Science, Beni-Suef University, Beni-Suef 65211, Egypt.
May N Bin JumahDepartment of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0002-3017-9924
Saleha A AlZahraniDepartment of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
Ahmed A AllamZoology Department, Faculty of Science, Beni-Suef University, Beni-Suef 65211, Egypt.
Mostafa R AbukhadraGeology Department, Faculty of Science, Beni-Suef University, Beni-Suef 65211, Egypt.ORCID 0000-0001-5404-7996
Stefano BellucciINFN-Laboratori Nazionali di Frascati, Via E. Fermi 54, 00044 Frascati, Italy.ORCID 0000-0003-0326-6368
Beni-Suef University · EGPrincess Nourah bint Abdulrahman University · SAIstituto Nazionale di Fisica Nucleare, Laboratori Nazionali di Frascati · IT

Funding

Princess Nourah bint Abdulrahman University RGP-1443-0050
6 · The paper itself

Abstract

Natural kaolinite underwent advanced morphological-modification processes that involved exfoliation of its layers into separated single nanosheets (KNs) and scrolled nanoparticles as nanotubes (KNTs). Synthetic nanostructures have been characterized as advanced and effective oxaliplatin-medication (OXAP) delivery systems. The morphological-transformation processes resulted in a remarkable enhancement in the loading capacity to 304.9 mg/g (KNs) and 473 mg/g (KNTs) instead of 29.6 mg/g for raw kaolinite. The loading reactions that occurred by KNs and KNTs displayed classic pseudo-first-order kinetics (R

Indexed as

KaolinNanotubesKineticsOxaliplatinPharmaceutical PreparationsKaolinOxaliplatinPharmaceutical Preparationscytotoxicityexfoliationkaoliniteloadingmethanoloxaliplatin

Identifiers

PMID37446820
PMCPMC10343709
OpenAlexW4382982155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.